CCM
PROF

Corsair Capital Management’s Profound Medical PROF Stock Holding History

Corsair Capital Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,420
Closed -$208K – 175
2025
Q4 		$208K Buy
+26,420
New +$170K 0.03% 137

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Corsair Capital Management's PROF Position: Q1 2026 in Review

Corsair Capital Management sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 26,420 shares — an estimated $208K sold.

Corsair Capital Management first reported a position in PROF in Q4 2025 and held it in 1 quarter. The position peaked at $208K in Q4 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Corsair Capital Management reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
  • Corsair Capital Management sold 26,420 Profound Medical shares in Q1 2026, an estimated $208K.
  • Corsair Capital Management first reported a position in Profound Medical in Q4 2025 and held it in 1 quarter.
  • Corsair Capital Management's Profound Medical position peaked at $208K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Corsair Capital Management's 13F filing for Q1 2026, filed 15 May 2026.